Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125001) titled 'A Clinical Study on the Efficacy and Safety of Inusimab Injection for Lipid-Regulating Therapy in Adult Patients with Primary Hypercholesterolemia or Mixed Dyslipidemia Intolerant or Poorly Responsive to Statins' on May 20.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Xianning Central Hospital
Condition:
Primary hypercholesterolemia and mixed dyslipidemia with statin intolerance or inadequate response
Intervention:
Experimental Group A:Inusimab Injection 150 mg, subcutaneous injection, once every 2 weeks, for 12 consecutive weeks of treatment
Recruitment Status: Not Recruiting ...